Anyone can talk about global health problems. But with a graduate degree from Boston University School of Public Health, you can take your place at the forefront of those who help solve them. Launch or advance your career with a master’s or doctoral program in one of eight public health concentrations: biostatistics, environmental health, epidemiology, health policy & management, international health, maternal & child health, social & behavioral sciences, and health law, bioethics & human rights. You’ll work with acclaimed faculty whose research and practice are building a healthier world, here at home and worldwide.
When he turned 75 a few years ago, Dr. Sidney Wolfe’s daughter and son-in-law presented him with a doll custom-made to look like him, with a button on it that played one sentence, over and over: “It’s an outrage!” [caption id="attachment_42106" align="alignleft" width="400"] Dr. Sidney Wolfe emphasizes a point during the 2014 Shine Lecture.[/caption] On Wednesday, as he delivered the 2014 Cathy Shine Lecture at the BU School of Public Health, Wolfe credited his sense of outrage with keeping him going for more than 40 years as head of the Public Citizen Health Research Group, which works to highlight lapses in oversight by
Forbes Magazine dubbed him “The FDA's Big Bad Wolfe.” He has battled the introduction of new medications by the pharmaceutical industry so aggressively that a Boston doctor once snapped, “Is there any drug Sid Wolfe likes?” After 40 years of holding federal regulators and the drug industry accountable, Dr. Sidney Wolfe, who will deliver the 2014 Cathy Shine Lecture at the BU School of Public Health on Wednesday, March 5 at noon, is accustomed to the jabs -- and even welcomes them. He prides the work of his Public Citizen Health Research Group on having pushed the Food and Drug Administration to take
In 2006, the nonprofit organization Choose Responsibility called for repealing the 1984 National Minimum Drinking Age Act, which had led all 50 states to establish a minimum legal drinking age of 21, and allowing the states to lower their limit to 18. Two years later, the organization assembled a small group of college and university presidents (the Amethyst Initiative) to call publicly for a critical reexamination of the law. Those moves prompted public health experts to generate new research on the age 21 limit. Now, a comprehensive review of that research led by William DeJong, professor of community health sciences at BUSPH,